US004 - The Chappel Group Research — Kissimmee, Florida

US004 - The Chappel Group Research is a clinical research site located in Kissimmee, Florida, United States 34744.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

US004 - The Chappel Group Research has participated in 1 clinical trials.

Therapeutic areas: Complex Regional Pain Syndrome (CRPS).

Sponsors: Grünenthal GmbH.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US004 - The Chappel Group Research?

US004 - The Chappel Group Research has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US004 - The Chappel Group Research conducted?

US004 - The Chappel Group Research has 1 clinical trials on record. Their work covers Complex Regional Pain Syndrome (CRPS).

Is US004 - The Chappel Group Research accredited by Crixeo Health?

US004 - The Chappel Group Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US004 - The Chappel Group Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.